ISEE News
Archived Headlines
- Ophthotech prices IPO at $22, above the upwardly revised range 09/25/13
- Eye disease biotech Ophthotech increases both shares offered and IPO price range 09/24/13
- 13 US IPOs planned for the week of Sep 23 09/23/13
- US IPO Recap: Twitter tweets its plans while eleven others set terms 09/16/13
- Eye disease biotech Ophthotech sets terms for $100 million IPO 09/09/13
See more
It's electric: Spark Therapeutics increases proposed IPO deal size by 48% to $130 million
Spark Therapeutics, which is developing gene therapy treatments for orphan retinal dystrophies, raised the proposed deal size for its upcoming IPO on Wednesday. The Philadelphia, PA-based company now plans to raise $130 million by offering 6.5 million...read more
Sustained-release eye pharmaceutical Ocular Therapeutix files for a $86 million IPO
Ocular Therapeutix, which develops and markets eye therapeutics using its sustained-release hydrogel platform, filed on Friday with the SEC to raise up to $86 million in an initial public offering. The Bedford, MA-based company, which was founded in 2006 and...read more
Rare eye disease biotech Applied Genetic Tech sets terms for $50 million IPO
Applied Genetic Technologies, a clinical-stage biotech developing treatments for orphan eye diseases, announced terms for its IPO on Wednesday. The Alachua, FL-based company plans to raise $50 million by offering 3.6 million shares at a price range of $13 to $15...read more
US IPO Recap: Foundation Medicine soars, Chrysler revs up for an IPO
Last week saw high levels of activity in the IPO market, as eleven companies priced, making this month the first September to have 20 deals since September of 2000. Health care and technology companies continued to dominate the space, with nine of the...read more